- Abridge and Kaiser Permanente debut Care Signals
- Built to Serve: The Day That Reminds Us Why We Chose Dentistry
- Journalists Catch You Up on Fauci Hearing, Peptides, and Kids’ Caffeine Consumption
- CMS finalizes 2.3% hospital pay bump, mandatory joint replacement model: 9 things to know
- How ambulatory shifts are reshaping perioperative strategy
- Cyclosporiasis cases top 18,000: 3 updates
- How Allegheny Health Network Strengthened its Foundation for IV Compounding Safety with Automation and Standardization¹
- Health plan customer service reps have AI in their ear
- Centene’s buyouts could have a $315M+ price tag for the rest of the year
- Medicare pay cut sparks specialty battle over skin cancer care
- Cardiovascular Institute of New England provides notice of data incident
- CMS locks in 2.3% inpatient hospital base pay increase, nudges back CJR-X Model start date
- Why autonomy — not just capital — is winning over cardiologists
- The $36 vs. $95 problem: How RVU negotiations are skewing physician pay
- Mississippi hospital board member, former CEO remembered as advocate for rural communities
- Pennsylvania SUD treatment locator reaches 146K users
- Top 10 dental, DSO stories in July
- Ohio youth treatment facility faces scrutiny over reported abuse: 8 notes
- What dental leaders told us in July
- Urban hospital closures and net change, by state
- ADSO sues Colorado Dental Board over practice ownership rule
- New patient acquisition is the top growth driver for dental practices: Report
- 20 new behavioral health projects to know
- Nurses, patients protest North Star Health Alliance ASC closure
- No Surprises Act under attack by payers: 8 things to know
- Dental staffing wages up 23% since 2021: ADA
- AtlantiCare appoints anesthesiology, gastroenterology physician leaders
- Consumer dental spending up 24% over 10 years: 5 stats to know
- Baylor Scott & White joint venture expands outpatient behavioral health services
- 5 DSOs making headlines
- VA to explore GLP-1 treatment for alcohol use disorder: 4 notes
- A $5B wave of M&A hits the ASC industry
- FTC Sues Hims & Hers Over Health Privacy And Billing Practices
- 145 physician medical groups led all healthcare M&A sectors in Q1
- 10 new ASCs in July
- Healthcare exec, telemedicine company owner sentenced for $35M DME fraud scheme
- Amylyx demystifies post-bariatric hypoglycemia with patient education website
- What Dad Eats Before Conception May Influence Baby's Health
- Family History Plays Role In Genetic Risk For Breast Cancer, Researchers Find
- A look at employers' attitudes toward ICHRAs
- Revised 340B Rebate Model Pilot Program moves forward, despite provider pushback
- Function Health lands $450M in growth financing to scale tech-enabled preventive health
- Daiichi Sankyo flags accounting error, as shares tank despite revenue beat
- AbbVie's Skyrizi shrugs off new competition as it thrives in growing psoriasis market
- Op-ed: Hospitals on the edge, a time for CMS to do no harm
- Daily Routine Key To Good Health, Study Says
- Alignment Healthcare boasts 32% revenue jump in Q2, lifts 2026 outlook
- Xpovio mulligan in endometrial cancer comes up short as Karyopharm presses on in myelofibrosis
- Psilocybin Therapy Helps Ease Veterans' Severe PTSD, Pilot Study Finds
- Newsom Reverses On Long-Sought Paid Leave Benefit For California Teachers
- Nicotine Levels Are Rising Among Teens Who Vape, New Study Warns
- The Newest Federally Recognized Tribe Wants Better Healthcare. It May Be On Its Own.
- They Worked To Protect Public Health. Now They Want the Public’s Votes.
- 27 new behavioral health study findings to know
- 21 state behavioral health policy updates
- What will fuel the next wave of DSO growth
- Dentists’ biggest staffing headaches
- Shionogi makes the call on COVID pill Xocova TV spot
- Psilocybin-assisted therapy reduced PTSD symptoms: 3 notes
- Fierce Pharma Asia—Legend CEO exits; Merck’s hush-hush PD-1xVEGF plan; Otsuka’s novel ADHD nod
- Psychedelics, peptides and GLP-1s
- How 'physician-led' care team models tackle primary care's workforce problem
- How 7 systems divert behavioral health patients from the ED
- WellSpan Health, Hippocratic AI ink ‘multi-year’ partnership with plans to co-develop clinical AI agents
- Kaiser faces complaint over automated behavioral health triage system
- Free research hub Nila aims to demystify menopause, other hormone conditions
- Scientists Defend Fauci's Pandemic Work As Senate Hearing Turns Bitter
- Pfizer takes Litfulo to regulators in vitiligo challenge to Incyte, AbbVie
- Study Questions Effectiveness of Antihistamines in Easing Eczema
- Vaping Is Likely Reshaping The Future Of Cancer In The US, Study Argues
- Weekly Rundown: Counsel Health rolls out white label AI care platform; Community Health Network launches MyChart AI assistant
- New CEO Garijo sketches out vision to reverse Sanofi's fortunes as Q2 delivers impressive sales beat
- Alnylam shares tank 29% as Amvuttra disappoints with ATTR outlook cut for 2026
- Waystar boosts 2026 outlook as AI-powered RCM solutions gain traction with providers
- YouTuber MrBeast welcomes Amgen to the channel, kicking off pediatric cancer funding effort
- Booming Dupixent sales fuel Regeneron's biggest quarter since pandemic
- Sugar Consumption Early In Life Linked To Increased Dementia Risk, World War II-Era Data Show
- Work Stress Harming Middle-Age Sleep, Study Says
- RFK Jr.'s Gardasil litigation ties subject to fresh lawmaker scrutiny after Merck settlement
- Bristol Myers delays Cobenfy Alzheimer’s psychosis readout again amid another quarterly beat
- Hospice's Bad Reputation Amid Fraud Crisis Will Hurt Patients, Industry Experts Warn
- Cell Phone Ownership Linked To Lower Reading Skills In Elementary Students
- Listen to the Latest ‘KFF Health News Minute’
- Abortion Drug Law in Louisiana Heightens Hemorrhage Risk for Pregnant Patients
- Medicaid Insurers’ Contracts on the Line in Tight Governor’s Race
- Teladoc Health trims 2026 revenue forecast amid challenges with BetterHelp insurance shift
- Cigna CEO: Express Scripts seeing 'significant early interest' from clients for new rebate-free PBM model
- Viatris runs into FDA roadblock after advertising on-the-go use of cystic fibrosis inhaler
- Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues
- FTC sues Hims & Hers over data privacy, billing practices
- CMS' proposed 340B reimbursement cut—who wins, and who loses?
- Virtual care helps patients improve their gambling disorder symptoms, Birches Health finds
- Case Western Reserve University launches next-generation healthcare leadership program
- Lilly, Resilience commit $750M to boost US diabetes, obesity med production
- CMS ending Medicare Part D subsidy program
- Red Cross Declares Rare National Blood Supply Crisis Amid Summer Shortfall
- Not Just Pregnancy Fatigue: Could It Be Sleep Apnea?
- More Women Drinking During Pregnancy
- Wellstar Health System lays off 761 corporate, administrative staff
- Biogen flips '26 guidance from expected decline to sales increase
- Teva’s innovation engine offsets generics slump, leaving one analyst ‘shocked’ by Ajovy’s surge
- Talking To Your Baby? Eye Contact Is Key To Language Development, Experiment Shows
- Boosted by CMS settlement, Incyte expects Opzelura to cross $1B in 2026
- Leapfrog launches expanded ASC public reporting program
- Cyclospora Boosts Fears That Deadlier Foodborne Outbreaks Are Ahead
- DoorDash, GrubHub Delivering Junk Food To 1 In 4 Teens During School Hours
- Uninsured but Undaunted, a Surgical Patient Searched the Globe for a Deal
- Trump Has Quietly Throttled an Agency Devoted to the Safety of American Healthcare
- Hospice’s Bad Reputation Amid Fraud Crisis Will Hurt Patients, Industry Experts Warn
- Humana plans more market exits for 2027, CFO says
- PMCPA sanctions melatonin drugmaker over misleading information
- CG Life embraces next-gen era in merger with AI-native agency The Considered+AI
- How 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval
- Fifth Death Reported In NYC Legionnaires' Disease Outbreak
- Many Young Adults Aren't Ready To Manage Their Own Healthcare, Poll Finds
- Can A Daily Multivitamin Help You Stay Active As You Age?
- Stellarus launches AI-powered health plan customer service representative copilot
- Prebiotic Soda Health Claims Questioned In New Nutrition Study
- Family-Based Childhood Obesity Program Helps Kids Cut Weight, Become Healthier
- To Afford Aging In Place, Older Adults Turn To 'Golden Girls' Housing
- Breakfast Can Help Teens Make Better Food Choices Throughout Their Day, Study Says
- Newsom Reverses on Long-Sought Paid Leave Benefit for Teachers in California
- FDA Panel Backs Two Peptides For Compounding, Rejects One
- How Accurate Are Photo-Based Calorie Apps? 4 Are Put To The Test
- Popular School Cafeteria Meals Need An Update To Meet Healthy Food Standards, Researchers Say
- Ovarian Syndrome Quadruples Heart Disease Risk In Women, Major Study Concludes
- Weed-Killing Chemical, Glyphosate, Linked To Premature Births In Humans, Study Says
- 'The Child Is Terrified': Doctors On Front Lines Of Measles Comeback Speak Out
- 'Yo-yo' Weight Loss Linked To Decline In Muscle Mass
- FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments
- Frequent Marijuana Use Linked To Higher Stress Hormone Levels
- Back Pain? Try Swimming, Study Says
- Ozempic Cuts Down Calorie Intake For At Least A Year, Even If Hunger Returns, Trial Finds
- Money Problems Might Make Your Brain Old Before Its Time, Study Suggests
- Black MS Patients Dying Younger Than White Ones, Study Finds
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- Remarks to the Small Business Capital Formation Advisory Committee
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- Senate HELP committee advances nominees for CDC director, HHS preparedness head
- Remarks before the American-Hellenic Chamber of Commerce
- Remarks at the Society for Corporate Governance Conference
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Statement on the 2026 Regulatory Agenda
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
Michigan healthcare freedom community forum
As usual, politics in 2024 is an upside-down world. He said, she said, who knows where the truth lives amid the lies?
The Gateway Pundit published one of the clearest statements I've seen yet regarding the presidential candidates and their positions on abortion.
Practical federalism at its finest.
https://www.thegatewaypundit.com/2024/08/frank-pavone-lets-stop-asking-wrong-questions-about/
Quote]
Frank Pavone: Let’s Stop Asking the Wrong Questions About Trump and Abortion
Recent headlines are all about Vice Presidential candidate J.D. Vance predicting on a Sunday morning talk show that, if re-elected, President Donald Trump would veto any national bill banning abortion.
As is so often the case with the legacy media, they were asking the wrong question.
So asking a question like NBC’s Kristen Welker asked is setting up a scenario that is totally devoid of reality.
Another unlikely scenario is a Democrat-controlled Congress sending to Trump the Women’s Health Protection Act, a radical piece of legislation that would undo every pro-life law in the nation.
I wonder why they didn’t ask about that.
I am still waiting for the interview in which the media ask about the actual pro-life measures that will be within the President’s power from day one, all of which he did in his first term. For instance:
- Will you reinstate the expanded Mexico City policy, which so efficiently kept U.S. tax dollars from flowing to abortion profiteers overseas?
- Will you reinstate the rule barring any organization that receives Title X funds for family planning from discussing abortion with their clients?
- Will you continue to appoint federal judges who understand that the right to life is fundamental to our Constitution?
- Will you have the United States once again sign on to the life-affirming Geneva Consensus Declaration?
- Will you again defund the U.N. Population Fund (UNFPA), which peddles abortion ideology in 150 nations?
- Will you reinstate the office of Conscience and Religious Freedom within the Department of Health and Human Services?
But, of course, the Trump-hating media are not interested in making the President seem reasonable to pro-life and pro-choice people alike, by reminding them that he supports pro-life measures that most Americans likewise support.
Anti-Trumpers don’t want to remind pro-life people of what he actually accomplished, because that might encourage rather than suppress the pro-life vote.
We already have the tools we need to change public policy in a second Trump term to better protect the unborn.
We need freedom of speech, so we can educate people on abortion; freedom of religion to activate churches to protect the unborn; freedom of assembly to allow for pro-life marches, rallies, protests and prayer vigils; and, importantly, existing pro-life laws, which actually keep some money away from abortion businesses and protect some babies.
These tools already are in our arsenal, but the Democrats want to take them away from us. They’re throwing peaceful pro-lifers in prison, censoring pro-life speech, trying to shut down pregnancy centers and canceling pro-life politicians.
President Trump is the best person to protect the tools we need in order to end abortion. We don’t need him to give pro-life speeches or commit to signing bills – like a national ban on abortion – that aren’t going to come to his desk in the first place.
We have to get him elected, because if the Democrats have their way, the pro-life movement will not have the political freedom to protect any babies.
And yet here we are, over the weekend and today, arguing on social media and in the press about whether we can support President Trump because, as some say, he’s “backing away” from the pro-life position.
In reality, the choice before us is not between President Trump and somebody better. It’s between President Trump and somebody worse. It’s between President Trump, who made it possible for states to protect the unborn, as many of them now do and will continue to do, and Kamala Harris, who wants to take away the ability of states to protect the unborn by making abortion a fundamental constitutional right.
I often say that mothers do not choose abortion because they have freedom of choice, but because they have no freedom and no choice. In this election, if we want to preserve our freedom to protect life, there is only one choice.
This Daily Signal commentary defends federalist strategy + pro-life goals in a way I haven't seen elsewhere. I like it: it makes me feel conservatives are regaining some of the ground that is their constitutional heritage.
https://www.dailysignal.com/2024/11/15/3-pro-life-policies-watch-trumps-second-term/
3 Pro-Life Policies to Watch for in Trump’s Second Term
Donald Trump is the most pro-life president in U.S. history. No other leader of the free world has matched his commitment to defending life, from defunding abortion providers to decisively reshaping the Supreme Court.
As we look to a second Trump term, two pro-life policies are likely to take center stage and immediately should be adopted.
A third—a national abortion ban—is not likely to get traction at this time.
1. Defund Planned Parenthood
Under President Joe Biden, Planned Parenthood received a record $750 million of taxpayer funding while performing a record 392,000 abortions just last year. The so-called nonprofit now gets roughly one-third of its total income from the federal government.
Defunding Planned Parenthood would be a major setback for the organization, which has already shown signs of mission drift and ineffective leadership in the post-Roe v. Wade era.
Since Cecile Richards left in 2018 after 12 years at the helm, the role of CEO at Planned Parenthood has become a chaotic evolving door, and the overturning of Roe didn’t help. The current leadership has been less effective in executing Planned Parenthood’s mission, as confirmed by both current and former employees.
In 2017, Trump sought to defund Planned Parenthood, but was blocked by then-Speaker of the House Paul Ryan and other Republicans lacking the political will and moral clarity to make it happen.
He revisited the idea in 2019 through Title X, which provides government funding to Planned Parenthood to distribute contraceptives and other so-called family planning. Just last month, shortly before the election, then-vice presidential candidate Sen. JD Vance, R-Ohio, affirmed the Republican ticket’s goal to defund Planned Parenthood under a second Trump administration.
This move also aligns with Trump’s stance that abortion is now a state issue and, therefore, federal funding should not be supporting it. Like many other nonprofits in the nation, Planned Parenthood should fund itself, rather than relying on federal handouts.
Additionally, we can expect Trump to both cut funding for Planned Parenthood International—Planned Parenthood’s arm in foreign countries—as he did in his first term, and reinstate the Mexico City Policy, one of his first actions as president in 2017, to prevent U.S. taxpayer dollars from funding overseas abortions.
2. Reregulating Abortion Pills
Following the overturning of Roe, the Centers for Disease Control and Prevention and the Food and Drug Administration dramatically expanded access to abortion pills by permitting them to be dispensed through pharmacies and even by mail, without requiring any in-person medical oversight.
Removing the need for a visit to a medical professional before taking these pills hardly qualifies as safe health care, likely contributing to the fact that 1 out of every 21 women who take them end up in the emergency room.
Reinstating basic regulations on abortion pills is a commonsense measure that even pro-abortion advocates once supported. Not least given the revelation of alarming medical statistics, it stands a strong chance of gaining traction with a Republican majority in Congress.
3. A National Abortion Ban
Since the Supreme Court chose not to apply the 14th Amendment to unborn children, abortion has been returned to the states. Although a federal abortion ban was quickly brought into the conversation, Trump has consistently stated he would not pursue one, and there’s no reason to expect he’d go back on his word.
Calls for a 15-week ban—an arbitrary gestational threshold—were considered, but ultimately rejected, by Trump. In a post-Roe America, where 25 states have already enacted strong pro-life laws, a 15-week ban would undermine their more protective legislation already in place, signaling weakness rather than progress. A 15-week ban would become the standard in all of those pro-life states that have already saved tens of thousands of babies with stricter bans or heartbeat bills that prevent abortions after six weeks of pregnancy.
Trump is sometimes accused of not listening to advisers, but the pro-life movement’s experience has shown otherwise. As a candidate, Trump admitted his limited knowledge of abortion, but took the time to educate himself. He listened to pro-life champions and accepted critical guidance from Federalist Society Chairman Leonard Leo and other Catholic leaders on Supreme Court nominations. This led directly to the overturning of Roe, an event many pro-life Americans never thought they’d witness.
In a second term, Trump is poised to remain a steadfast pro-life president. While pro-life Americans shouldn’t give him a free pass, it would be reckless and disrespectful to ignore his remarkable record.
Trump has demonstrated his commitment to the pro-life cause, and there’s every reason to believe he will govern with those values at the forefront once again.
Shawn Carney is president and CEO of the pro-life organization 40 Days for Life and the author of “What to Say When 2: Your Proven Guide in the New Abortion Landscape.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























